Item Details

Print View

Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials

editors, Betty Tai, Nora Chiang, Peter Bridge
Format
Book; Government Document
Published
Rockville, MD : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications ; [Washington, D.C. : Supt. of Docs., U.S. G.P.O., distributor], 1997.
Language
English
Series
NIDA Research Monograph
NIH Publication
SuDoc Number
HE 20.3965:175
Related Resources
Read online
Contents
  • Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research
  • Overview of potential treatment medications for cocaine dependence
  • Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective
  • Management of clinical trials with new medications for cocaine dependence and abuse
  • Outcome measurement considerations: pharmacological treatments for substance abuse
  • Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials --Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence
  • Addiction severity index in clinical efficacy trials of medications for cocaine dependence
  • Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment
  • Treatment effectiveness score as an outcome measure in clinical trials
  • Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis
  • Quantitative urine levels of cocaine and other substances of abuse
  • Use of quantitative urinalysis in monitoring cocaine use
  • Is quantitative urinalysis more sensitive?
  • Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine
  • Appendix I: Workshop summary outcome measures and success criteria
  • Appendix II: Workshop summary clinical decision tree for cocaine addiction pharmacotherapy.
Description
iv, 329 p. : ill. ; 24 cm.
Notes
  • "Based on the papers from a technical review ... held on October 20-21, 1994"--p. ii.
  • Includes bibliographical references.
Series Statement
NIDA research monograph ; 175
NIH publication no. 98-4125
Other Forms
Also available via Internet from the NIDA web site (PDF file only)
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 03503cam a2200445Ia 4500
    001 u3370950
    003 SIRSI
    008 980106s1997 mdua b f101 0 eng d
    020
      
      
    c| $20.00
    035
      
      
    a| (Sirsi) b3446980
    035
      
      
    a| b3446980
    035
      
      
    a| (OCoLC)38160933
    040
      
      
    a| MMU c| MMU d| GPO d| CNO d| VAL
    049
      
      
    a| VALU
    074
      
      
    a| 0831-C-12
    074
      
      
    a| 0831-C-12 (online)
    086
    0
      
    a| HE 20.3965:175
    245
    0
    0
    a| Medication development for the treatment of cocaine dependence : b| issues in clinical efficacy trials / c| editors, Betty Tai, Nora Chiang, Peter Bridge.
    260
      
      
    a| Rockville, MD : b| U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications ; a| [Washington, D.C. : b| Supt. of Docs., U.S. G.P.O., distributor], c| 1997.
    300
      
      
    a| iv, 329 p. : b| ill. ; c| 24 cm.
    440
      
    0
    a| NIDA research monograph ; v| 175.
    440
      
    0
    a| NIH publication v| no. 98-4125.
    500
      
      
    a| "Based on the papers from a technical review ... held on October 20-21, 1994"--p. ii.
    504
      
      
    a| Includes bibliographical references.
    505
    0
      
    a| Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research -- Overview of potential treatment medications for cocaine dependence -- Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective -- Management of clinical trials with new medications for cocaine dependence and abuse -- Outcome measurement considerations: pharmacological treatments for substance abuse -- Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials --Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence -- Addiction severity index in clinical efficacy trials of medications for cocaine dependence -- Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment -- Treatment effectiveness score as an outcome measure in clinical trials -- Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis -- Quantitative urine levels of cocaine and other substances of abuse -- Use of quantitative urinalysis in monitoring cocaine use -- Is quantitative urinalysis more sensitive? -- Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine -- Appendix I: Workshop summary outcome measures and success criteria -- Appendix II: Workshop summary clinical decision tree for cocaine addiction pharmacotherapy.
    530
      
      
    a| Also available via Internet from the NIDA web site (PDF file only)
    596
      
      
    a| 17
    650
      
    0
    a| Cocaine abuse x| Treatment v| Congresses.
    650
      
    0
    a| Clinical trials v| Congresses.
    700
    1
      
    a| Tai, Betty.
    700
    1
      
    a| Chiang, C. Nora.
    700
    1
      
    a| Bridge, Peter, c| M.D.
    856
    7
      
    z| View Online Version u| http://www.nida.nih.gov/pdf/monographs/monograph 175/download175.html 2| http z| Adobe Acrobat Reader required to view full document z| URL accesses introductory page, from which a link may be made to the full document.
    710
    2
      
    a| National Institute on Drug Abuse. b| Office of Science Policy and Communications.
    941
      
      
    a| 02-05-98 b| 04-01-98 c| 2
    948
      
      
    a| 02/05/98 b| 04/01/98 c| 02/05/98
    999
      
      
    a| HE 20.3965:175 w| SUDOC i| 35007002457152 l| LAW2-DOCS m| LAW t| DOCUMENT
▾See more
▴See less

Availability

Google Preview

Google Books Preview
Library Location Map Availability Call Number
Law 2nd Floor Documents Map Available